Clearside BioMedical Inc (CLSD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
October 2018
55
About the Report
About the Report
Summary
Clearside BioMedical Inc (Clearside) is a clinical biopharmaceutical company that develops treatments for vision impairment associated with uveitic macular edema. The company's pipeline products comprise Uveitis, macular edema associated with non- infectious uveitis; RVO-Retinal Vein Occlusion and DME-Diabetic Macular Edema and wet age related macular degeneration (wet AMD). Clearside's proprietary suprachoroidal treatment approach offers unprecedented access to the back of the eye where sight threatening disease often occurs. The company also offers services such as business development, license agreements and contract manufacturing services. It markets its products across the US. Clearside is headquartered in Alpharetta, Georgia, the US.
Clearside BioMedical Inc (CLSD)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Clearside BioMedical Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Clearside BioMedical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Clearside BioMedical Inc, Medical Devices Deals, 2012 to YTD 2018 10
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Clearside Biomedical Raises USD0.3 Million in Venture Financing 13
Clearside Biomedical Raises USD20 Million in Series C Financing 14
Clearside Biomedical Raises USD16 Million in Series B Venture Financing 15
Clearside Biomedical Raises USD 8 Million In Venture Financing 17
Clearside Biomedical Raises Additional Funds In Series A Financing 19
Partnerships 20
Clearside Biomedical Enters into Agreement with EyeKor 20
Santen Expands Research Agreement with Clearside Biomedical 21
Santen Enters Into Research Agreement With Clearside Biomedical 22
Licensing Agreements 23
NovaMedica Enters into Licensing Agreement with Clearside Biomedical 23
Clearside Biomedical Enters into Licensing Agreement with Emory University and GTRC 24
Equity Offering 25
Clearside Biomedical Prices Public Offering of Shares for USD85 Million 25
Clearside BioMedical Prices Public Offering of Shares for USD36 Million 27
Clearside Biomedical Raises USD50.4 Million in IPO 29
Clearside BioMedical Inc-Key Competitors 31
Clearside BioMedical Inc-Key Employees 32
Clearside BioMedical Inc-Locations And Subsidiaries 33
Head Office 33
Recent Developments 34
Financial Announcements 34
Aug 08, 2018: Clearside Biomedical announces second quarter 2018 financial results and provides corporate update 34
May 09, 2018: Clearside Biomedical Announces First Quarter 2018 Financial Results 37
Mar 14, 2018: Clearside Biomedical Reports Fourth Quarter 2017 Financial Results 38
Nov 08, 2017: Clearside Biomedical Announces Third Quarter 2017 Financial Results and Provides Corporate Update 41
Aug 09, 2017: Clearside Biomedical Announces Second Quarter 2017 Financial Results and Provides Corporate Update 43
May 10, 2017: Clearside Biomedical Announces First Quarter 2017 Financial Results and Provides Corporate Update 45
Mar 14, 2017: Clearside Biomedical Announces Fourth Quarter And Full Year 2016 Financial Results 47
Corporate Communications 49
Sep 27, 2018: Clearside Biomedical appoints Jeffrey Edwards to board of directors 49
Sep 11, 2018: Clearside Biomedical names Leslie Zacks as General Counsel and Chief Compliance Officer 50
Feb 26, 2018: Clearside Biomedical Appoints William Humphries As Board Chairman And Brion Raymond As Chief Commercial Officer 51
Aug 08, 2017: Clearside Biomedical Announces Changes to its Board of Directors 53
Jan 04, 2017: Clearside Biomedical Appoints Richard Beckman, M.D., as Chief Medical Officer 54
Appendix 55
Methodology 55
About GlobalData 55
Contact Us 55
Disclaimer 55
List of Figure
List of Figures
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Clearside BioMedical Inc, Medical Devices Deals, 2012 to YTD 2018 10
List of Table
List of Tables
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Clearside BioMedical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Clearside BioMedical Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Clearside BioMedical Inc, Medical Devices Deals, 2012 to YTD 2018 10
Clearside BioMedical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Clearside Biomedical Raises USD0.3 Million in Venture Financing 13
Clearside Biomedical Raises USD20 Million in Series C Financing 14
Clearside Biomedical Raises USD16 Million in Series B Venture Financing 15
Clearside Biomedical Raises USD 8 Million In Venture Financing 17
Clearside Biomedical Raises Additional Funds In Series A Financing 19
Clearside Biomedical Enters into Agreement with EyeKor 20
Santen Expands Research Agreement with Clearside Biomedical 21
Santen Enters Into Research Agreement With Clearside Biomedical 22
NovaMedica Enters into Licensing Agreement with Clearside Biomedical 23
Clearside Biomedical Enters into Licensing Agreement with Emory University and GTRC 24
Clearside Biomedical Prices Public Offering of Shares for USD85 Million 25
Clearside BioMedical Prices Public Offering of Shares for USD36 Million 27
Clearside Biomedical Raises USD50.4 Million in IPO 29
Clearside BioMedical Inc, Key Competitors 31
Clearside BioMedical Inc, Key Employees 32
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.